Potential supervisors and their fields of research are featured below.
Dr Jenny Chalmers: firstname.lastname@example.org
Implications of alcohol pricing policy for alcohol and illicit drug use; alcohol industry responses to government efforts to increase the price of alcohol; unmet demand for alcohol and drug treatment.
Dr Katrina Champion: email@example.com
Multiple health behaviour change, prevention and early intervention of alcohol and other drug use, Internet-based interventions, randomised controlled trials.
Professor Jan Copeland: firstname.lastname@example.org
Cannabis, evaluation of information dissemination methodologies, psycho-social and pharmacotherapy intervention trials for cannabis use related problems and disorder, measurement and monitoring of treatment outcome, and women’s treatment.
Professor Louisa Degenhardt: email@example.com
Epidemiology of illicit drug use (especially cannabis, amphetamines, cocaine and heroin), mortality among illicit drug users, drug use among young people, crime among heroin dependent people, injecting drug use, pharmaceutical opioid use, including by people who are living with chronic pain.
Dr Caitlin Hughes: firstname.lastname@example.org
Drugs and crime; impacts of drug laws, policing and criminal justice policies; drug law reform; police and court diversion; drug markets, supply and trafficking.
Dr Sarah Larney: email@example.com
Opioid dependence and related harms, including hepatitis C virus, injecting related injuries and diseases, and contact with the criminal justice system. Dr Larney is particularly seeking a PhD student to undertake work on a population-level linked dataset of opioid treatment episodes, hospital admissions and emergency department visits.
Dr Suzanne Nielsen: firstname.lastname@example.org
Treatment and prevention strategies for pharmaceutical drug dependence, over-the-counter codeine dependence, long-term outcomes for pharmaceutical opioid dependent people, acute and chronic pain management for opioid dependent people, benzodiazepine use amongst opioid dependent people. Methodological expertise includes clinical trials, including lab-based psychopharmacological studies, interview based data- collection and online surveys, prospective cohort studies.
Dr Katrina Prior: email@example.com
Anxiety; comorbid anxiety and substance use disorders; prevention and early intervention of mental health and/or alcohol and other drug use; randomised controlled trials; internet-based programs for young people.
Professor Anthony Shakeshaft: firstname.lastname@example.org
Intervention research, including prevention, early intervention, clinical services and policy agencies. Particular areas of interest are interventions in collaboration with Indigenous Australians and in rural/remote communities.
Associate Professor Tim Slade: email@example.com
Epidemiology of alcohol use and alcohol use disorders, particularly in adolescence and young adulthood; diagnosis and classification of mental and substance use disorders with a focus on DSM-5.
Dr Emily Stockings: firstname.lastname@example.org
Mental health services, policy, prevention and treatment provision, comorbid mental and physical conditions, smoking cessation, smoke-free policy, randomised controlled trials, intervention research.
Professor Maree Teesson: email@example.com
Mental disorders and drug and alcohol use; prevention; trials in adolescents; clinical trials of new treatments; adolescent brain development and drug use.